Ticker Scorecard - CTLT Basics Company: CATALENT, INC. IPO Date: July 31, 2014 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Activated in VL: False Average Daily Range Avg Daily Range: $0.78 | 1.40% Avg Daily Range (30 D): $0.21 | 0.34% Avg Daily Range (90 D): $0.23 | 0.38% Institutional Daily Volume Avg Daily Volume: 1.12M Avg Daily Volume (30 D): 1.45M Avg Daily Volume (90 D): 1.35M Trade Size Avg Trade Size (Sh.): 89 Avg Trade Size (Sh.) (30 D): 169 Avg Trade Size (Sh.) (90 D): 118 Institutional Trades Total Inst.Trades: 12,332 Avg Inst. Trade: $3.97M Avg Inst. Trade (30 D): $3.39M Avg Inst. Trade (90 D): $3.75M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $10.18M Avg Closing Trade (30 D): $35.04M Avg Closing Trade (90 D): $20.11M Avg Closing Volume: 169.88K     News Dec 14, 2024 @ 5:08 AM Novo Nordisk A/S: The acquisition of Catalent by N... Source: N/A Dec 6, 2024 @ 6:11 PM The European Commission approves the acquisition o... Source: N/A Nov 27, 2024 @ 11:31 AM Pharmaceutical Contract Development and Manufactur... Source: Globe Newswire Nov 14, 2024 @ 9:58 AM High Potency API Contract Manufacturing Market For... Source: Researchandmarkets.Com Oct 18, 2024 @ 6:39 PM After US Senator, Unions Urge Federal Trade Commis... Source: Vandana Singh Financials   TTM TTM Q1 2025 Basic EPS $-2.29 $-.71 Diluted EPS $-2.29 $-.71 Revenue $ $ 4.42B $ 1.02B Gross Profit $ $ 965M $ 181M Net Income / Loss $ -17M $ -413M $ -129M Operating Income / Loss $ $ -90M $ -67M Cost of Revenue $ $ 3.46B $ 842M Net Cash Flow $ $ 126M $ 46M PE Ratio